Upregulation of lncRNA BCAR4 accelerates the malignant development of non-small cell lung cancer, indicating BCAR4 might serve as a potential biomarker for non-small cell lung cancer treatment [18]. Here, BCAR4 is linked to non-small cell lung carcinoma.